ANYSIS

The Anysis system test provides assessment for inherited, acquired, or drug-induced platelet dysfunction.

Through in-vivo vascular mimicking microfluidics, the system measures a realistic primary hemostasis associated with platelet function.

Total Platelet Function Assay

  • Anysis C/ADP test,  Anysis-C/Epinephrine test 

  • Screens platelet function for impaired primary hemostasis, such as von Willebrand disease

  • Provides high sensitivity for congenital platelet dysfunction, such as Glanzmann thrombasthenia

  • Anysis-Aspirin test,  Anysis-P2Y12 test

  • Assesses platelet dysfunction caused by Aspirin

  • Detects platelet dysfunction caused by P2Y12-receptor inhibitors

  • Anysis-SIPA

  • Assesses Shear-Induced Platelet Activation and Aggregation

Key Features of Anysis

  • Whole blood hemostasis assay

  • Similar to in vivo vascular environment

  • Test time: Less than 4 minutes / test

  • Sample volume: 200uL 

  • Upstream-activation & downstream assay 

  • ECM mimicked microbead-packed tube 

  • Platelet-adhesion induced closure

  • Blood migration-distance assay

Upstream Activation - Downstream Adhesion

Activation

Adhesion

Aggregation

Occlusion

Detection

Anysis is a...

Operator-independent Results

Measurements are not affected by operator's skillfulness

Stenosed Thrombosis Model

Flow through microbeads mimics stenosed vascular thrombosis

Platelet-Adhesion Characteristic

Adhesion characteristic is fully emphasized in microscale pores

Fully Automated System

With a single pipetting, the whole test is automatically operated

Bubble-free Test

Air bubbles in blood sample are naturally excluded in the test

Hematocrits-independent

Hematocrit variations do not affect the measurement of Anysis

Platelet Function Tests

Location

RheoMeditech Inc.,

32 Anam-ro, 2F

Dongdaemun-gu,

Seoul, Korea 02578

Tel: +82-2-537-5111

Fax: +82-2-537-5103

Copyright 2019 © RheoMeditech Inc. All Rights Reserved